Stocksigma LogoStocksigma Logo

Sun Pharma Shareholders Approve ESOP 2026, Enhanced Borrowing, and Investment Limits

Sun Pharmaceutical Industries announced the approval of all special resolutions via postal ballot concluded on 31st Oct'26

Sun Pharma Shareholders Approve ESOP 2026, Enhanced Borrowing, and Investment Limits

Sun Pharmaceutical Industries Ltd 路 Others (Uncategorized) 路 01 Nov 2026, 1:44 am

Sun Pharma Shareholders Approve ESOP 2026, Enhanced Borrowing, and Investment Limits Sun Pharmaceutical Industries announced the approval of all special resolutions via postal ballot concluded on 31st Oct'26. Shareholders approved the Sun Pharma Employees Stock Option Plan 2026 ("ESOP 2026"), including trust funding, secondary share acquisitions, and scheme extension to subsidiary employees. Additionally, members cleared key capital-structuring resolutions, including enhanced investment and lending limits under Section 186, expanded borrowing limits under Section 180(1)(c), creation of security under Section 180(1)(a) of the Companies Act, 2013, and creation of encumbrances over shares pursuant to SEBI Listing Regulations.

Original exchange filing (PDF)

More announcements from Sun Pharmaceutical Industries Ltd

All Sun Pharmaceutical Industries Ltd announcements